Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $295 | $198 | $226 | $21 |
| - Cash | $18 | $22 | $13 | $14 |
| + Debt | $60 | $45 | $31 | $10 |
| Enterprise Value | $338 | $221 | $244 | $18 |
| Revenue | $42 | $34 | $22 | $34 |
| % Growth | 22.1% | 57.3% | -35.6% | – |
| Gross Profit | $14 | $21 | $9 | $21 |
| % Margin | 32.8% | 61.3% | 42.6% | 61.1% |
| EBITDA | -$36 | -$4 | -$23 | -$9 |
| % Margin | -87.3% | -12.2% | -105.5% | -27.9% |
| Net Income | -$40 | -$11 | -$25 | -$16 |
| % Margin | -96% | -32.6% | -113.6% | -46.6% |
| EPS Diluted | -0.008 | -0.002 | -0.005 | -0.006 |
| % Growth | -265.2% | 55.8% | 10.3% | – |
| Operating Cash Flow | -$29 | -$8 | -$21 | -$11 |
| Capital Expenditures | -$2 | -$2 | -$2 | -$2 |
| Free Cash Flow | -$31 | -$9 | -$23 | -$13 |